Whanin Pharm Total Liabilities

Latest as of June 2026: ₩57.15 Billion KRW ≈ $38.73 Million USD

Whanin Pharm total liabilities. Based on the latest financial reports, Whanin Pharm (016580) has total liabilities worth ₩57.15 Billion KRW (≈ $38.73 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Whanin Pharm's assets to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Whanin Pharm (2009–2025)

Total liabilities of Whanin Pharm from 2009 to 2025. This chart illustrates how Whanin Pharm's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Whanin Pharm to see how much of total assets are deployed in long-term investments.

Whanin Pharm Competitors by Total Liabilities

The table below lists competitors of Whanin Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Draganfly Inc NASDAQ:DPRO	USA	$5.16 Million
Gurit Holding AG SW:GURN	Switzerland	CHF182.25 Million
Thac Mo Hydropower JSC VN:TMP	Vietnam	₫556.00 Billion
Ekovest Bhd KLSE:8877	Malaysia	RM8.39 Billion
Interactive Digital Technologies TWO:6486	Taiwan	NT$1.53 Billion
Cheffelo AB ST:CHEF	Sweden	Skr325.82 Million
P.C.S. Machine Group Holding Public Company Limited BK:PCSGH	Thailand	฿741.11 Million
First Farms A/S CO:FFARMS	Denmark	Dkr784.70 Million

Liability Composition Analysis (2009–2025)

This chart breaks down Whanin Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 016580 total assets.

Liquidity & Leverage Metrics

Whanin Pharm Total Liabilities Ratios Explained

Whanin Pharm total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	4.26	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.13	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.12	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Whanin Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Whanin Pharm (2009–2025)

The table below shows the annual total liabilities of Whanin Pharm from 2009 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩57.88 Billion ≈ $39.23 Million	+18.85%
2024-12-31	₩48.70 Billion ≈ $33.01 Million	+13.22%
2023-12-31	₩43.02 Billion ≈ $29.15 Million	+21.36%
2022-12-31	₩35.45 Billion ≈ $24.02 Million	-1.44%
2021-12-31	₩35.96 Billion ≈ $24.37 Million	+9.12%
2020-12-31	₩32.96 Billion ≈ $22.33 Million	+8.33%
2019-12-31	₩30.42 Billion ≈ $20.62 Million	+8.26%
2018-12-31	₩28.10 Billion ≈ $19.04 Million	-11.50%
2017-12-31	₩31.75 Billion ≈ $21.52 Million	+36.22%
2016-12-31	₩23.31 Billion ≈ $15.80 Million	+23.35%
2012-12-31	₩18.90 Billion ≈ $12.81 Million	+16.26%
2011-12-31	₩16.25 Billion ≈ $11.02 Million	+54.67%
2009-12-31	₩10.51 Billion ≈ $7.12 Million	--

About Whanin Pharm

KO:016580 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$130.27 Million

₩192.23 Billion KRW

Market Cap Rank

#18023 Global

#774 in Korea

Share Price

₩10400.00

Change (1 day)

-0.76%

52-Week Range

₩9230.00 - ₩11930.00

All Time High

₩24391.10